Behavioral Intervention

clinician-mediated JASPER for Autism Spectrum Disorder

UCLA, Los Angeles, CA
Targeting 2 different conditionsclinician-mediated JASPER +1 moreN/ARecruitingResearch Sponsored by University of California, Los Angeles

Study Summary

This trial will study whether JASPER, a play-based intervention, is effective in treating children with autism spectrum disorder. The trial will last 3 years, recruiting 90 participants (10 per site per year) from Boston University, UCLA, and Weill Cornell. The participants will be randomized to receive JASPER from either a clinician or their caregiver, and after 10 weeks, will be evaluated to see if they respond to the treatment. Nonresponders will then receive a mix of clinician and caregiver-facilitated JASPER, while responders will continue to receive the same treatment for an additional 10 weeks. The outcome of

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~entry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry)
This trial's timeline: 3 weeks for screening, Varies for treatment, and entry (1st month of the study), t2 (10 weeks after entry), t3 (20 weeks after entry) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in frequency of language utterances and number of conversation turns using the Elicitation of Language Samples for Analysis- Toddlers (ELSA-T)
Change in social communication using the Brief Observation of Social Communication Change (BOSCC)
Other outcome measures
ADOS Toddler Module or Module 1 or Module 2 (depends on child's language level)
Change in Joint Engagement on the Caregiver-Child Play Interaction (CCX) over the course of the study.
Demographic and Medical Questionnaire
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: parent-mediated JASPERExperimental Treatment1 Intervention
This group will consist of the therapist assisting the parent implement JASPER on the child twice a week.
Group II: clinician-mediated JASPERExperimental Treatment1 Intervention
This group will consist of the child and therapist having one-on-one, JASPER sessions, twice a week.

Find a site

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,467 Previous Clinical Trials
10,148,752 Total Patients Enrolled
24 Trials studying Autism Spectrum Disorder
4,259 Patients Enrolled for Autism Spectrum Disorder
Simons FoundationOTHER
7 Previous Clinical Trials
6,166 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
1,141 Patients Enrolled for Autism Spectrum Disorder

Media Library

JASPER (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04146428 — N/A
Autism Spectrum Disorder Research Study Groups: clinician-mediated JASPER, parent-mediated JASPER
Autism Spectrum Disorder Clinical Trial 2023: JASPER Highlights & Side Effects. Trial Name: NCT04146428 — N/A
JASPER (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04146428 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been selected to take part in this research initiative?

"To fulfill the trial requirements, 90 individuals who meet all of the eligibility criteria must participate. The Semel Institute in Boston and BU White Plains are two medical centers which currently offer this clinical trial."

Answered by AI

Does this research still have vacancies open to the public?

"According to the documents, enrollment is still open for this trial that was first advertised on 27th April 2021 and last modified on 2nd September 2022."

Answered by AI

Does this research endeavor include elderly individuals as participants?

"This experiment is seeking to enrol participants aged between 18 months and 5 years."

Answered by AI

What criteria must potential participants fulfill in order to join this experiment?

"This trial is seeking 90 participants that are between 18 months and 5 years old, diagnosed with autism spectrum disorder."

Answered by AI
~15 spots leftby Apr 2024